PW Medtech Group Limited (1358.HK)

HKD 1.0

(-0.99%)

EBITDA Summary of PW Medtech Group Limited

  • PW Medtech Group Limited's latest annual EBITDA in 2023 was 329.48 Million CNY , up 90.69% from previous year.
  • PW Medtech Group Limited's latest quarterly EBITDA in 2024 Q2 was 131 Million CNY , down 0.0% from previous quarter.
  • PW Medtech Group Limited reported an annual EBITDA of 175.49 Million CNY in 2022, up 125.04% from previous year.
  • PW Medtech Group Limited reported an annual EBITDA of 77.98 Million CNY in 2021, up 2550.58% from previous year.
  • PW Medtech Group Limited reported a quarterly EBITDA of 153.92 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • PW Medtech Group Limited reported a quarterly EBITDA of 134.88 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of PW Medtech Group Limited (2023 - 2012)

Historical Annual EBITDA of PW Medtech Group Limited (2023 - 2012)

Year EBITDA EBITDA Growth
2023 329.48 Million CNY 90.69%
2022 175.49 Million CNY 125.04%
2021 77.98 Million CNY 2550.58%
2020 2.94 Million CNY -95.75%
2019 69.27 Million CNY -15.36%
2018 81.84 Million CNY 27.04%
2017 64.42 Million CNY -53.03%
2016 137.15 Million CNY -53.92%
2015 297.66 Million CNY 7.09%
2014 277.95 Million CNY 44.16%
2013 192.81 Million CNY 36.27%
2012 138.15 Million CNY 0.0%

Peer EBITDA Comparison of PW Medtech Group Limited

Name EBITDA EBITDA Difference
Kaisa Health Group Holdings Limited 27.56 Million HKD -1095.465%
Elegance Optical International Holdings Limited -51.64 Million HKD 737.962%
Arts Optical International Holdings Limited 77.08 Million HKD -327.416%
Kelfred Holdings Limited 14.24 Million HKD -2213.128%
Modern Dental Group Limited 696.64 Million HKD 52.704%